DA Approves Canakinumab for Gout Flares The US FDA has approved canakinumab Ilaris for the treatment of gout flares in adults who cannot be treated with NSAIDs, colchicine, or repeated courses of corticosteroids. https://t.co/OX3wIajQtm https://t.co/tMDMc8ZKE8